Rabconnectin-3-binding protein
Abstract
A protein useful for clarifying the regulation mechanism of Ca 2+ -dependent exocytosis in particular, the activation and inactivation of Rab3A, and a method of screening for a material useful for regulating Ca 2+ -dependent exocytosis in particular, the activation and inactivation of Rab3A, using the above protein. By using the coimmunoprecipitation with an anti-Rab3A GEP antibody, a protein participated in the regulation of activation or inactivation of Rab3A is determined. As the protein binds to rabconnectin-3 and GDP/GTP exchange protein, it can be used for screening for a material that increases or decreases the binding.
Claims
exact text as granted — not AI-modified1 . A protein as defined in (a) or (b):
(a) a protein comprising the amino acid sequence of SEQ ID NO: 2; and (b) a protein comprising the amino acid sequence of SEQ ID NO: 2 with one or several amino acids deleted, replaced, or added, and having an activity of binding rabconnectin-3 and a GDP/GTP exchange protein.
2 . The protein of claim 1 , which has the amino acid sequence of SEQ ID NO: 2.
3 . A polynucleotide that encodes a protein as defined in claim 1 .
4 . The polynucleotide of claim 3 , comprising the nucleotide sequence of SEQ ID NO: 1.
5 . A polynucleotide as defined in (a) or (b):
(a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1; and (b) a polynucleotide which hybridizes with a polynucleotide comprising a nucleotide sequence that is complementary to the nucleotide sequence of SEQ ID NO: 1 under a stringent condition, and encodes a protein having an activity of binding rabconnectin-3 and a GDP/GTP exchange protein.
6 . A polynucleotide as defined in (a) or (b):
(a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1; and (b) a polynucleotide comprising a nucleotide sequence whose homology to the nucleotide sequence of SEQ ID NO: 1 is 80% or higher and encoding a protein having an activity of binding rabconnectin-3 and a GDP/GTP exchange protein.
7 . A recombinant vector comprising a polynucleotide as defined in any one of claims 3 to 6 .
8 . A transformant obtained by transforming a host with a polynucleotide as defined in any one of claims 3 to 6 .
9 . A method of producing a protein having an activity of binding rabconnectin-3 and a GDP/GTP exchange protein, comprising:
culturing a transformant as defined in claim 8 in a culture; and collecting, from the culture, a protein having an activity of binding rabconnectin-3 and the GDP/GTP exchange protein.
10 . (Canceled)
11 . A method of analyzing a first polynucleotide as defined in any one of claims 3 to 6 , comprising hybridizing a probe or a primer with the first polynucleotide, wherein the probe or primer includes a second polynucleotide having at least 15 nucleotides complementary to the first polynucleotide.
12 . The analyzing method of claim 11 , wherein the first polynucleotide is present in a tissue or a cell.
13 . A method of analyzing a first polynucleotide encoding a protein as defined in claim 1 or 2 , comprising hybridizing a probe or a primer with the first polynucleotide, wherein the probe or primer includes a second polynucleotide having at least 15 nucleotides complementary to the first polynucleotide.
14 . The analyzing method of claim 13 , wherein the first polynucleotide is present in a tissue or a cell.
15 . A method comprising amplifying an mRNA in a tissue or a cell by an RT-PCR method with a primer that includes a polynucleotide having at least 15 nucleotides complementary to a polynucleotide as defined in any one of claims 3 to 6 .
16 . An antisense polynucleotide which hybridizes with an mRNA encoding a protein as defined in claim 1 or 2 .
17 . A ribozyme for cutting an mRNA encoding a protein as defined in claim 1 or 2 .
18 . A double-stranded RNA for cutting an mRNA encoding a protein as defined in claim 1 or 2 by RNA interference.
19 . An antibody against a protein as defined in claim 1 or 2 .
20 . A method of immunohistologically analyzing a protein as defined in claim 1 or 2 , comprising contacting the protein with an antibody as defined in claim 19 .
21 . The method of claim 20 , further comprising determining the location of the protein.
22 . The method of claim 20 , further comprising determining the amount of expression of the protein.
23 . A method of screening for a material that promotes or inhibits binding between a protein as defined in claim 1 or 2 or a heterogeneous homologous protein thereof, and rabconnectin-3, comprising the steps of:
contacting a protein as defined in claim 1 or 2 or a heterogeneous homologous protein thereof with rabconnectin-3 in the presence and absence of candidate materials, and selecting a material which increases or decreases binding between the protein and rabconnectin-3.
24 . A method of screening for a material that promotes or inhibits binding between a protein as defined in claim 1 or 2 or a heterogeneous homologous protein thereof, and a Rab 3 GDP/GTP exchange protein, comprising the steps of:
contacting a protein as defined in claim 1 or 2 or a heterogeneous homologous protein thereof with Rab3 GDP/GTP exchange protein in the presence and absence of candidate materials, and selecting a material which increases or decreases binding between the protein and Rab3 GDP/GTP exchange protein.
25 . A polynucleotide that encodes a protein as defined in claim 2 .
26 . A recombinant vector comprising a polynucleotide as defined in claim 25 .
27 . A transformant obtained by transforming a host with a polynucleotide as defined in claim 25 .
28 . A method of producing a protein having an activity of binding rabconnectin-3 and a GDP/GTP exchange protein, comprising:
culturing a transformant as defined in claim 27 in a culture; and collecting, from the culture, a protein having an activity of binding rabconnectin-3 and the GDP/GTP exchange protein.
29 . A method of analyzing a first polynucleotide as defined in claim 25 , comprising hybridizing a probe or a primer with the first polynucleotide, wherein the probe or primer includes a second polynucleotide having at least 15 nucleotides complementary to the first polynucleotide.
30 . The analyzing method of claim 11 , wherein the first polynucleotide is present in a tissue or a cell.
31 . A method comprising amplifying an mRNA in a tissue or a cell by an RT-PCR method with a primer that includes a polynucleotide having at least 15 nucleotides complementary to a polynucleotide as defined in claim 25.Join the waitlist — get patent alerts
Track US2005064430A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.